Communication, Recruitment and Enrolment in the Preventative and Therapeutic Phase I Clinical Trial Against HIV/AIDS Based on the Recombinant HIV-1 Tat Protein

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV - United Kingdom
doi 10.1080/09540121.2010.542124
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Phase I Clinical Trial of an Intranodally Administered mRNA Based Therapeutic Vaccine Against HIV-1 Infection

AIDS
Infectious DiseasesAllergyImmunology
2018English

Antibody Against Human Immunodeficiency Virus Type 1 (HIV-1) Tat Protein May Have Influenced the Progression of AIDS in HIV-1-infected Hemophiliac Patients.

Clinical and diagnostic laboratory immunology
1996English

In Vitro Nuclear Interactome of the HIV-1 Tat Protein

Retrovirology
VirologyInfectious Diseases
2009English

Synthetic HIV-1 Matrix Protein P17-Based AT20-KLH Therapeutic Immunization in HIV-1-infected Patients Receiving Antiretroviral Treatment: A Phase I Safety and Immunogenicity Study

BMC Infectious Diseases
Infectious Diseases
2014English

HBV X Protein Targets HIV Tat-Binding Protein 1

Virology
Virology
2001English

Ketone Bodies Protection Against HIV-1 Tat-Induced Neurotoxicity

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2012English

The Cross-Talk of HIV-1 Tat and Methamphetamine in HIV-associated Neurocognitive Disorders

Frontiers in Microbiology
Microbiology
2015English

Exosome-Associated Release, Uptake, and Neurotoxicity of HIV-1 Tat Protein

Journal of NeuroVirology
VirologyNeurologyCellularMolecular Neuroscience
2016English

HIV-1 Tat and T Cell Apoptosis

Retrovirology
VirologyInfectious Diseases
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy